Todd Dickinson

  • June 13, 2013  

    In a unanimous decision, the Supreme Court justices ruled that a company cannot patent an isolated human gene. To look at the implications of the decision and its impact for patients and medical research, Judy Woodruff talks to Todd Dickinson of the American Intellectual Property Law Association and Sandra Park of the ACLU. Continue reading